Jennifer Agger Kandolin, M.S, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 420 South Jackson St., Jackson, WY 83002 Phone: 307-413-0536 |
Larry Adam Williamson, LCPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 640 E Broadway Ave, Jackson, WY 83001 Phone: 307-733-2046 Fax: 307-733-6289 |
Rindala Miller, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 8605 Centennial Dr, Jackson, WY 83001 Phone: 509-254-3438 |
Kristin Poole Counselor - Professional Medicare: Medicare Enrolled Practice Location: 640 E Broadway Ave, Jackson, WY 83001 Phone: 307-733-2046 Fax: 307-733-6289 |
Susan Ann Juvelier, LPC LAT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1215 W Angus Dr, Jackson, WY 83001 Phone: 307-733-8535 |
Leah B Chase, PPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 640 E Broadway, Jackson, WY 83001 Phone: 307-733-2046 Fax: 307-733-6289 |
Deidre Ashley Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 640 E Broadway Ave, Jackson, WY 83001 Phone: 307-733-2046 Fax: 307-733-6289 |
News Archive
A new study reveals that tumors release factors into the bloodstream that inhibit the repair of damaged muscle fibers, and that this contributes to muscle loss during cancer wasting.
Janet Woodcock, director of the Center for Drug Evaluation and Research at FDA, on Thursday at a Senate hearing said that the number of medication ingredients manufactured abroad limits the ability of the agency to ensure the safety of all treatments sold in the U.S., CQ HealthBeat reports (Carey, CQ HealthBeat, 4/24).
Martin McKee, Professor of European Health at the London School of Hygiene & Tropical Medicine has contributed one of three commentaries appearing today in the journal Health Policy and Planning, each of which take a different perspective on the World Health Report 2000 on health systems (WHR2000).
BioTrends Research Group, Inc. released Wave 2 of its LaunchTrends(TM): Feraheme report, the second in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15.
NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists
› Verified 6 days ago